$2.41T
Total marketcap
$72.9B
Total volume
BTC 50.90%     ETH 14.96%
Dominance

Integra LifeSciences Holdings Corporation IL3.F Stock

30.8 EUR {{ price }} -2.531649% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
2.42B EUR
LOW - HIGH [24H]
30.8 - 30.8 EUR
VOLUME [24H]
100 EUR
{{ volume }}
P/E Ratio
39.48
Earnings per share
0.78 EUR

Integra LifeSciences Holdings Corporation Price Chart

Integra LifeSciences Holdings Corporation IL3.F Financial and Trading Overview

Integra LifeSciences Holdings Corporation stock price 30.8 EUR
Previous Close 37.6 EUR
Open 37.6 EUR
Bid 37.6 EUR x N/A
Ask 37.8 EUR x N/A
Day's Range 37.6 - 37.6 EUR
52 Week Range 35.6 - 56.5 EUR
Volume 40 EUR
Avg. Volume 2 EUR
Market Cap 3.08B EUR
Beta (5Y Monthly) 1.160915
PE Ratio (TTM) 19.481865
EPS (TTM) 0.78 EUR
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 77.7 EUR

IL3.F Valuation Measures

Enterprise Value 4.42B EUR
Trailing P/E 19.481865
Forward P/E 10.994151
PEG Ratio (5 yr expected) 1.42
Price/Sales (ttm) 1.9717373
Price/Book (mrq) 1.8384509
Enterprise Value/Revenue 2.829
Enterprise Value/EBITDA 11.323

Trading Information

Integra LifeSciences Holdings Corporation Stock Price History

Beta (5Y Monthly) 1.160915
52-Week Change -25.098%
S&P500 52-Week Change 20.43%
52 Week High 56.5 EUR
52 Week Low 35.6 EUR
50-Day Moving Average 46.31 EUR
200-Day Moving Average 49.18 EUR

IL3.F Share Statistics

Avg. Volume (3 month) 2 EUR
Avg. Daily Volume (10-Days) 4 EUR
Shares Outstanding 81.9M
Float 70.81M
Short Ratio N/A
% Held by Insiders 13.08%
% Held by Institutions 94.59%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 11.00%
Operating Margin (ttm) 17.32%
Gross Margin 62.89%
EBITDA Margin 24.98%

Management Effectiveness

Return on Assets (ttm) 4.56%
Return on Equity (ttm) 10.44%

Income Statement

Revenue (ttm) 1.56B EUR
Revenue Per Share (ttm) 18.92 EUR
Quarterly Revenue Growth (yoy) 1.09%
Gross Profit (ttm) 982.03M EUR
EBITDA 390.26M EUR
Net Income Avi to Common (ttm) 171.88M EUR
Diluted EPS (ttm) 1.93
Quarterly Earnings Growth (yoy) -26.40%

Balance Sheet

Total Cash (mrq) 323.03M EUR
Total Cash Per Share (mrq) 3.94 EUR
Total Debt (mrq) 1.61B EUR
Total Debt/Equity (mrq) 96.32 EUR
Current Ratio (mrq) 3.647
Book Value Per Share (mrq) 20.452

Cash Flow Statement

Operating Cash Flow (ttm) 246.28M EUR
Levered Free Cash Flow (ttm) 212.63M EUR

Profile of Integra LifeSciences Holdings Corporation

Country Germany
State NJ
City Princeton
Address 1100 Campus Road
ZIP 08540
Phone 609 275 0500
Website https://www.integralife.com
Industry Medical Devices
Sector(s) Healthcare
Full Time Employees 3722

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

Q&A For Integra LifeSciences Holdings Corporation Stock

What is a current IL3.F stock price?

Integra LifeSciences Holdings Corporation IL3.F stock price today per share is 30.8 EUR.

How to purchase Integra LifeSciences Holdings Corporation stock?

You can buy IL3.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Integra LifeSciences Holdings Corporation?

The stock symbol or ticker of Integra LifeSciences Holdings Corporation is IL3.F.

Which industry does the Integra LifeSciences Holdings Corporation company belong to?

The Integra LifeSciences Holdings Corporation industry is Medical Devices.

How many shares does Integra LifeSciences Holdings Corporation have in circulation?

The max supply of Integra LifeSciences Holdings Corporation shares is 78.6M.

What is Integra LifeSciences Holdings Corporation Price to Earnings Ratio (PE Ratio)?

Integra LifeSciences Holdings Corporation PE Ratio is 39.48718000 now.

What was Integra LifeSciences Holdings Corporation earnings per share over the trailing 12 months (TTM)?

Integra LifeSciences Holdings Corporation EPS is 0.78 EUR over the trailing 12 months.

Which sector does the Integra LifeSciences Holdings Corporation company belong to?

The Integra LifeSciences Holdings Corporation sector is Healthcare.